Highlights for the second quarter include:
-- Record net revenue of $177.0 million, up 27% year-over-year
-- Record originations of $2.8 billion, up 31% year-over-year
-- Improved Contribution Margin to 48.3% from 47.3% in the same quarter last
year
-- Delivered Adjusted EBITDA of $25.7 million, or a 14.5% Adjusted EBITDA
margin, up 11.3 percentage points year-over-year reflecting the company's
efforts to drive profitability
-- GAAP Consolidated Net Loss was $(60.8) million, or $(6.7) million
excluding $35.6 million of goodwill impairment related to the Company's
patient and education finance unit, which reflects the Company's focus on
growing the direct to consumer marketplace and $18.5 million of expenses